You are now leaving www.admabiologics.com
The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/03/21 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
29 | |
| 02/02/21 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | |
| 02/01/21 | 8-K | Current report filing |
|
   |
3 |
| 01/26/21 | 8-K | Current report filing |
|
|
3 |
| 01/19/21 | 8-K | Current report filing |
|
|
4 |
| 01/04/21 | 8-K | Current report filing |
|
|
2 |
| 12/16/20 | 8-A12B | Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b) |
|
4 | |
| 12/16/20 | 8-K | Current report filing |
|
|
35 |
| 12/09/20 | 8-K | Current report filing |
|
|
9 |
| 11/05/20 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
38 |
